Deal Flow Tracker
User Title
email@vitalant.org
Dashboard
Add Deal
Companies
Deals In Review
Deals Completed
Archived
Company Information
Company Name *
Company Description *
ECI Therapeutics (ECI) develops products from donated, pathogen-reduced plasma. EC I's platform leverages plasma in combination with a novel chitosan to deliver growth factors and proteins that promote the healing of epithelial (surface cell) disorders such as dry eye disease and chronic wounds.
Website
Industry Type
Industry Type
BioTherapy
Hematology
Other
Unassigned
Incoming Channel
Contact Information
CEO
COO
CCO
CFO
CTO
CMO
Vitalant Account/Presentation
Relationship Owner *
Relationship Owner
Becky Cap
Bhavi Shah
Dave Green
FullName
Maureen Musselman
Ralph Vassallo
Rob Van Tuyle
Unassigned
Initial V. Engagement Date
Save
Cancel
Add Key Question
Key Question
Add Note
Note details
Add Action
Contact Action is with
Team Representative
Relationship Owner
Becky Cap
Bhavi Shah
Dave Green
FullName
Maureen Musselman
Ralph Vassallo
Rob Van Tuyle
Unassigned
Type of Contact
Type of Contact
Call
Create Document
Email
Enter Data
Fax
Presentation
Publish Document
Research
Verify
Unassigned
Date
Notes
Add Attachment
Attachment Type
Attachment Type
Cap Table
Company Data Room
Company Presentation
Fully Executed DNA
Name
Strategic Vitalant Operations
Supporting Documentation
Vitalant Presentation
Unassigned
Description
File
Note: Maximum Upload Size is 12MB